Hall & Partners’ US Managing Partner for Health, Stacy Vaughn, wrote an article for PharmaExec: ‘Purposeful Partnerships for Post-COVID Era‘.
Never before has pharma’s purpose been more clearly recognised. And this is important. In a recent global healthcare research study by Hall & Partners in partnership with Porter Novelli, more than 90% of healthcare professionals–and 80% percent of payers–said that a pharma company’s ability to demonstrate its purpose impacts their prescribing decisions. This is especially the case when drug treatments are perceived at parity in price, efficacy or safety.
Now is the time for healthcare companies to address expectations in the post pandemic world, capitalising on this newfound trust and addressing conditions that have been pushed aside.
Pharma should be the ‘glue’ that bonds healthcare organisations together to solve society’s most pressing challenges.Stacy Vaughn
Pharmaceutical Executive provides its audience of pharmaceutical and biopharmaceutical executives with the analysis of business, strategy, and government regulations.